基本分析
透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。
基本資料
個股的基本資料,以及所屬的類股和產業。
公司介紹
業務介紹
波士頓科學公司在全球範圍內開發、製造和銷售用於各種介入性醫療專科的醫療器械。該公司通過三個業務部門運營:醫療外科、心律及神經、心血管。該公司提供用於診斷和治療胃腸和肺部疾病的器械;用於治療各種泌尿和骨盆疾病的器械;可植入式心律轉復除顫器和可植入式心臟再同步化療除顫器;起搏器和可植入式心臟再同步化療起搏器;以及遠程患者管理系統。它還提供用於診斷和治療心率和心律失常的醫療技術,包括3D心臟製圖和導航解決方案、消融導管、診斷導管、製圖導管、心內超聲導管、輸送鞘和其他配件;用於慢性疼痛管理的脊髓刺激器系統;間接減壓系統;以及深部腦刺激系統。此外,該公司還提供介入性心臟病學產品,包括用於冠狀動脈疾病治療的藥物洗脫冠狀動脈支架系統;用於治療動脈粥樣硬化的經皮冠狀動脈介入產品;用於冠狀動脈和心腔以及各種外周血管的血管內導管定向超聲成像導管、分數流保留裝置和系統;以及結構性心臟治療。此外,該公司還提供用於治療動脈疾病的支架、球囊導管、導線和粥樣斑塊切除系統;用於治療靜脈疾病的血栓切除和聲波溶栓系統、導線和支架;以及用於治療癌症的外周栓塞裝置、放射性微球、消融系統、低溫消融系統以及微型和引流導管。該公司成立於1979年,總部位於馬薩諸塞州的馬爾伯勒。
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.
警語
1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。
2. 資料並不完整,需要完整資料請至相關網站索取。
3. 任何股市數據分析皆存在倖存者偏差。